✦ LIBER ✦

A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer

✍ Scribed by Ciuleanu, T.; Tsai, C.-M.; Tsao, C.-J.; Milanowski, J.; Amoroso, D.; Heo, D.S.; Groen, H.J.M.; Szczesna, A.; Chung, C.-Y.; Chao, T.-Y.; Middleton, G.; Zeaiter, A.; Klingelschmitt, G.; Klughammer, B.; Thatcher, N.

Book ID: 122214845
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 718 KB
Volume: 82
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2013.08.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab combined with pemetrexed plu

Bevacizumab combined with pemetrexed plus cisplatin followed by maintenance bevacizumab/pemetrexed as first-line treatment of advanced non-squamous non-small cell lung cancer: A single-arm Phase 2 study

✍ Santoro, Armando; Hillerdal, Gunnar N.; Hoeffken, Gert; Favaretto, Adolfo; Carri 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 596 KB

Phase II study of oral S-1 plus cisplati

Phase II study of oral S-1 plus cisplatin with bevacizumab for advanced non-squamous non-small cell lung cancer

✍ Kaira, Kyoichi; Tomizawa, Yoshio; Yoshino, Reiko; Miura, Yosuke; Yoshii, Akihiro 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 684 KB

Chemotherapy plus bevacizumab in the fir

Chemotherapy plus bevacizumab in the first-line treatment of non-small cell lung cancer: benefits, risks and limitations

✍ F. Grossi; A. Brianti; C. Defferrari; P. Pronzato 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 124 KB

Efficacy of bevacizumab plus erlotinib v

Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial

✍ Roy S Herbst; Rafat Ansari; Frederique Bustin; Patrick Flynn; Lowell Hart; Grego 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 338 KB

Randomized phase II study of first-line

Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer

✍ Niho, Seiji; Kunitoh, Hideo; Nokihara, Hiroshi; Horai, Takeshi; Ichinose, Yukito 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 408 KB

Clinical genotyping and efficacy outcome

Clinical genotyping and efficacy outcomes: Exploratory biomarker data from the phase II ABIGAIL study of first-line bevacizumab plus chemotherapy in non-squamous non-small-cell lung cancer

✍ Pallaud, Celine; Reck, Martin; Juhasz, Erzsebet; Szima, Barna; Yu, Chung-Jen; Bu 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 405 KB